Ioannis Zerdes

STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer

Ioannis Zerdes, Majken Wallerius, Emmanouil G. Sifakis et al. · Cancers · 2019 · 96 citations · Full text

Life Sciences, Immunology, Oncology +17

SETD2 mutation in renal clear cell carcinoma suppress autophagy via regulation of ATG12

Patricia González-Rodríguez, Pinelopi Engskog‐Vlachos, Hanzhao Zhang et al. · Cell Death and Disease · 2020 · 61 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer

Thomas Hatschek, Theodoros Foukakis, Judith Bjöhle et al. · JAMA Oncology · 2021 · 56 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Immune gene expression and response to chemotherapy in advanced breast cancer

Theodoros Foukakis, John Lövrot, Alexios Matikas et al. · British Journal of Cancer · 2018 · 52 citations · Full text

Medicine, Immunology, Oncology +15

Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial

Alexios Matikas, Hemming Johansson, Per Grybäck et al. · Clinical Cancer Research · 2022 · 41 citations

Medicine, Immunology, Oncology +17